The suggested mechanism involves therefore increased plasma concentrations of apolipoprotein C3, which in turn inhibits lipoprotein lipase and triglyceride clearance, and consequently increases fasting and post-prandial hypertriglyceridaemia. The gene discussed is APOC3; the disease is hypertriglyceridemia.